COO, INARI MEDICAL
WHY: Exec tapped to take over a company on a fast track. Revenue is expected to grow 33% this year to $369M and another 20% in 2023, according to analysts’ consensus estimates. Inari has developed products from the ground up with a specific purpose to remove clots from veins.
IN THE NEWS: Taking over CEO role from Bill Hoffman on Jan. 1, 2023. Joined Inari in 2017 as chief commercial officer before becoming COO in 2020, leading its day-to-day business operations.
QUOTABLE: “We have maintained an unwavering commitment to our patients, our people and to big ideas.”
